AI assistant
Sending…
ELI LILLY & Co — Director's Dealing 2023
Feb 3, 2023
29745_dirs_2023-02-03_782bafb5-6dd3-4a70-a521-25663a339a03.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2022-12-31
Reporting Person: Ricks David A (Director, President, Chair, and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-08-15 | Common Stock | G | 32467 | — | Disposed | 365316 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 63500 | Indirect |
| Common Stock | 70000 | Indirect |
| Common Stock | 7169 | Indirect |
Footnotes
F1: The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F2: On May 11, 2022, the Reporting Person transferred 70,000 shares of Eli Lilly and Company common stock to a Grantor Retained Annuity Trust, of which the Reporting Person is the trustee.
More from ELI LILLY & Co
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29